GLP-1 Medications and Bone Health During Weight Loss: What the Science Actually Says

Weight loss medications like semaglutide and tirzepatide have changed the lives of millions of people. The results can be remarkable. But alongside the excitement, a quieter conversation has been building in medical circles, and it is worth having.

Research published in 2024 found that people taking semaglutide at weight-loss doses faced a meaningfully higher risk of bone fractures. That is a real finding. It is also a manageable one, as long as you know what you are dealing with.

This article is not here to scare you away from a treatment that may genuinely help you. It is here to lay out what the evidence shows, why it happens, and most importantly, what you can do about it.

---

What the Research Actually Found

The largest and most discussed study on this topic is the SELECT trial, published in JAMA Internal Medicine in 2024. Researchers followed 17,604 adults without diabetes for an average of 3.3 years. Half received semaglutide at 2.4 mg. The other half received a placebo. The difference in fracture rates was striking. People in the semaglutide group were 28 percent more likely to experience a fracture compared to those taking the placebo.

That number sounds alarming. It should be put in context. Fractures in the semaglutide group occurred most often in the hands, wrists, ankles, and feet. These are not the classic osteoporotic fractures of the hip or spine that people often picture when they hear the word osteoporosis. The increased risk was real, but it played out in specific parts of the body.

A 2022 cohort study published in JAMA looked at electronic health records and found a similar pattern. People using GLP-1 agonists had a higher rate of fractures compared to people using other diabetes medications, especially for non-vertebral fractures. The association held even after researchers adjusted for other factors that could explain the difference.

To be clear, this does not mean GLP-1 medications cause osteoporosis in the way that steroids do. The mechanisms appear to be different. But the increased fracture risk is not hypothetical. It is documented in well-designed studies with thousands of participants.

---

Why Weight Loss Affects Bones in the First Place

Before blaming the medication, it helps to understand a broader truth. Weight loss of any kind tends to affect bone density, whether the weight comes off through diet, exercise, bariatric surgery, or medication. That is not opinion. It is physiology.

When you carry less body weight, your bones experience less mechanical load. Think of bone as a tissue that constantly rebuilds itself in response to the demands you place on it. When you walk, run, and move with more weight, your skeleton works harder to support that load and stays stronger as a result. When you lose weight, especially quickly, that stimulus decreases. The bones adapt by becoming less dense.

Research from Beddhu and colleagues in 2023 outlined several mechanisms driving this effect. Some are directly related to GLP-1 medications. Others are simply what happens when the body loses weight fast.

One key mechanism involves reduced mechanical loading. Less body weight means your bones are under less stress, which signals osteoclasts, the cells that break down bone tissue, to become more active than osteoblasts, the cells that build new bone. This is the same reason astronauts lose bone density rapidly in microgravity. There is simply not enough resistance for the skeleton to maintain itself.

Another factor is calcium absorption. GLP-1 medications slow gastric emptying and can reduce stomach acid production. The intestines need an acidic environment to absorb calcium efficiently. When that environment changes, less calcium gets into your bloodstream, and bones have to give up some of their stored mineral to keep blood levels stable.

There is also the issue of muscle loss. GLP-1 medications do not selectively target fat. Some of the weight lost is muscle. Sarcopenia, the progressive loss of muscle mass, reduces the mechanical anchoring that muscles provide to bones and cuts off the production of myokines, hormones released by muscle tissue that support bone remodeling. The Ozempro app can help you track your nutritional intake and physical activity during treatment, making it easier to spot gaps that might be affecting both muscle and bone health.

Beyond those, researchers have identified a handful of other pathways. Rapid fat burning produces ketone bodies, which can create a mild state of metabolic acidosis. In that environment, bones dissolve slightly to release alkaline minerals that buffer the blood pH. Caloric restriction also tends to lower IGF-1 levels, a growth factor that plays an important role in bone formation. Elevated cortisol from chronic restriction and increased parathyroid hormone from altered vitamin D metabolism both push bone loss in the same direction.

The picture that emerges is not that GLP-1 medications are uniquely toxic to bone. It is that they produce rapid weight loss, and rapid weight loss, from any source, stresses the skeleton.

---

Who Faces the Highest Risk

Not everyone taking a GLP-1 medication is in the same situation. Some people are starting from a more vulnerable place when it comes to bone health.

Women after menopause are at the top of that list. The sharp drop in estrogen that comes with menopause accelerates bone loss significantly. If you add rapid weight loss on top of that, the cumulative effect on bone density can be substantial. Women in this stage already face elevated fracture risk even without medication.

Men over 65 are also at higher risk. Testosterone levels decline with age, and this hormone plays a direct role in maintaining bone mass. The combination of lower testosterone and weight loss medication can compound the problem.

Beyond age and sex, a family history of osteoporosis is a meaningful red flag. Genetics influence how your bones respond to stress and nutritional changes. People who have already had a fracture after age 50 should be particularly cautious. Low calcium and vitamin D intake, a sedentary lifestyle, concurrent use of corticosteroids, and a starting BMI above 35 all add layers of risk.

If any of those describe your situation, it is worth bringing up specifically with your doctor before or shortly after starting a GLP-1 medication.

---

Practical Steps to Protect Your Bones

The good news is that bone health is not a passive outcome. There are concrete things you can do that genuinely move the needle.

Resistance training is the single most powerful tool. Lifting weights, using resistance bands, or doing bodyweight exercises creates mechanical stress on your skeleton that directly stimulates bone formation. Many people assume that only calcium matters for bones. That is an oversimplification. Muscle and bone talk to each other constantly. When you challenge your muscles, you challenge your bones at the same time. The recommended target is two to three sessions per week, targeting the major muscle groups.

Protein intake deserves attention as well. During weight loss, your body is already at risk of losing muscle along with fat. Getting enough protein, roughly 1.2 to 1.5 grams per kilogram of body weight daily, helps preserve lean mass, which in turn protects bone indirectly through the muscle-bone connection and the myokines mentioned earlier.

Calcium should come primarily from food when possible. Dairy products, canned fish with soft edible bones, tofu made with calcium sulfate, and dark leafy greens like kale and bok choy are all solid sources. Supplements should only be considered if a blood test shows a deficiency or if your diet genuinely falls short. More is not better when it comes to calcium supplementation.

Vitamin D is the partner nutrient that makes calcium absorption possible. Sunlight exposure, fatty fish, fortified foods, and supplementation when necessary all help. Most adults benefit from 1,000 to 2,000 IU per day, though your doctor can tell you what makes sense based on a blood test.

Speaking of blood tests, a DEXA scan before or shortly after starting a GLP-1 medication gives you a baseline. You cannot track changes if you do not know where you started. This is especially important for anyone with one or more of the risk factors described above.

Weight loss rate matters too. Faster is not always better when it comes to the skeleton. If your treatment protocol allows, increasing the dose more gradually may reduce the mechanical shock to your bones. This is a conversation to have with your prescribing physician.

Finally, pay attention to the basics. Avoid smoking, limit alcohol, prioritize sleep, and manage stress. All of these influence cortisol levels, and chronic cortisol elevation is a known driver of bone loss.

---

The Bottom Line

GLP-1 medications are effective tools for weight management and metabolic health. For many people, the benefits are substantial and the risks are manageable. The bone fracture signal identified in the SELECT trial and other studies is real, but it is not a reason to avoid treatment. It is a reason to enter treatment prepared.

Understanding what is happening in your body, knowing your baseline bone density, and taking active steps to support your skeleton during weight loss puts you in control. You do not have to choose between losing weight and having strong bones. With the right plan, you can work toward both at the same time.

If you are currently on a GLP-1 medication or planning to start one, bring up bone health at your next appointment. Ask about a DEXA scan, review your calcium and vitamin D status, and talk through an exercise plan that includes resistance work. These steps take a little effort, but they make a real difference.

For additional support tracking your nutrition, physical activity, and treatment goals during your GLP-1 journey, learn more here.